Related references
Note: Only part of the references are listed.TLR4 Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease in Comparison to Healthy Controls
Safak Kiziltas et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2014)
APOC3 and PNPLA3 in non-alcoholic fatty liver disease: Need to clear the air
Ajay Duseja et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Meta-Analysis of the Influence of I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) on the Susceptibility and Histological Severity of Nonalcoholic Fatty Liver Disease
Silvia Sookoian et al.
HEPATOLOGY (2011)
A Comparison of Sample Size and Power in Case-Only Association Studies of Gene-Environment Interaction
Geraldine M. Clarke et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Chantal A. Rivera et al.
BMC GASTROENTEROLOGY (2010)
Nonalcoholic Fatty Liver in a Developing Country is Responsible for Significant Liver Disease
Ajay Duseja et al.
HEPATOLOGY (2010)
Homozygosity for the Patatin-Like Phospholipase-3/Adiponutrin I148M Polymorphism Influences Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Luca Valenti et al.
HEPATOLOGY (2010)
Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease
Kitt Falk Petersen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease
Thomas Von Hahn et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Nonalcoholic fatty liver disease: from clinical recognition to treatment
Vassilios A Sevastianos et al.
Expert Review of Gastroenterology & Hepatology (2008)
The clinicopathological profile of indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the west
Ajay Duseja et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease
C. P. Day
LIVER INTERNATIONAL (2006)
Increased risk of NASH in patients carrying the C(-159) T polymorphism in the CD14 gene promoter region
P. Brun et al.
GUT (2006)
The toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia
C Marsik et al.
CLINICAL CHEMISTRY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
The TLR4+896 polymorphism is not associated with lipopolysaccharide hypo-responsiveness in leukocytes
SD Imahara et al.
GENES AND IMMUNITY (2005)
Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease
G Tal et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling
C Erridge et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR
NWJ Schröder et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections
DM Agnese et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Toll-like receptor 4 polymorphisms and atherogenesis
S Kiechl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
TLR4 and LPS hyporesponsiveness in humans
DA Schwartz
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2002)
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
S Chitturi et al.
HEPATOLOGY (2002)
Toll-like receptors in the induction of the innate immune response
A Aderem et al.
NATURE (2000)
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
NC Arbour et al.
NATURE GENETICS (2000)
Share Paper
